| Literature DB >> 31732858 |
Rebecca Upsher1, Maya Allen-Taylor2, Ilse Reece2, Mark Chamley3, Khalida Ismail4, Angus Forbes2, Kirsty Winkley2.
Abstract
INTRODUCTION: Type 2 diabetes is a progressive condition and many people require insulin therapy 5-10 years post diagnosis. Considering the global increase in type 2 diabetes, group education programmes to initiate insulin are beneficial as they are cost-effective and provide peer support. However, group education to initiate insulin has not been widely evaluated and there is a need to elicit the views and experience of people with type 2 diabetes who start insulin in groups. The aim of this study was to explore the perspectives of people with type 2 diabetes who receive nurse-led group-based insulin education.Entities:
Keywords: Diabetes nurse; Education; Health care delivery; Insulin therapy; Psychological aspects; Self-management; Type 2 diabetes
Year: 2019 PMID: 31732858 PMCID: PMC6965558 DOI: 10.1007/s13300-019-00727-7
Source DB: PubMed Journal: Diabetes Ther ISSN: 1869-6961 Impact factor: 2.945
Topic guide for interview schedule
| Reasons for referral to diabetes specialist team |
| Need for insulin, barriers to uptake and adherence |
| Benefits of insulin |
| Disadvantages of insulin |
| Delay in insulin? |
| Concerns/worries before insulin initiation |
| Views on insulin self-management support |
| Views on group insulin education |
| Positive views on insulin self-management support |
| Less positive/helpful aspects of insulin self-management support |
| Readiness to initiate insulin |
| Follow-up support |
| Recommendations for future insulin education support |
Overall demographics of interviewees with type 2 diabetes
| Characteristics | Number | Percentage | Mean (SD) |
|---|---|---|---|
| Age | 61.40 (10.58) | ||
| ≤ 45 | 2 | 13.3 | |
| 46–59 | 5 | 33.3 | |
| 60+ | 8 | 53.3 | |
| Ethnicity | |||
| Black African/Caribbean | 9 | 60.0 | |
| Caucasian | 5 | 33.3 | |
| Asian/other | 1 | 6.7 | |
| Gender | |||
| Female | 8 | 53.3 | |
| Male | 7 | 46.7 | |
| Diabetes duration | 11.33 (7.18) | ||
| HbA1c | 73.53 (21.49) | ||
| Insulin type | |||
| Humulin I | 11 | 73.3 | |
| Novomix 30 | 2 | 13.3 | |
| Lantus | 1 | 6.7 | |
| Abasaglar | 1 | 6.7 | |
| Oral antidiabetic medications | |||
| Zero | 2 | 13.3 | |
| Gliclazide only | 2 | 13.3 | |
| Metformin only | 2 | 13.3 | |
| Metformin and gliclazide | 2 | 13.3 | |
| Metformin, gliclazide, sitagliptin | 5 | 33.3 | |
| Metformin, gliclazide and linagliptin | 2 | 13.3 | |
| Glucagon-like peptide-1 | |||
| Zero | 12 | 80 | |
| Dulaglutide | 2 | 13.3 | |
| Liraglutide | 1 | 6.7 | |
Demographics of each interviewee with type 2 diabetes
| Participant number | Age group | Sex | Ethnic group |
|---|---|---|---|
| 1 | 46–59 | Female | Black African/Caribbean |
| 2 | 60+ | Female | Asian/other |
| 3 | 60+ | Female | White |
| 4 | 60+ | Male | White |
| 5 | 46–59 | Female | Black African/Caribbean |
| 6 | 60+ | Male | Black African/Caribbean |
| 7 | ≤ 45 | Male | Black African/Caribbean |
| 8 | 46–59 | Female | White |
| 9 | 60+ | Female | White |
| 10 | 60+ | Female | White |
| 11 | 60+ | Female | Black African/Caribbean |
| 12 | 46–59 | Male | Black African/Caribbean |
| 13 | 60+ | Male | Black African/Caribbean |
| 14 | 46–59 | Male | Black African/Caribbean |
| 15 | ≤ 45 | Male | Black African/Caribbean |
Fig. 1Summary of themes and subthemes
|
|
| There is global increase in the number of people with type 2 diabetes and as a result of its progressive nature more people will require insulin injection therapy. |
| Group education is a cost-effective approach to starting insulin requiring fewer diabetes nurse specialist educators. |
| This study aims to explore the perspectives of people with type 2 diabetes of group-based insulin education. |
|
|
| This qualitative research demonstrates that peer support and appropriate resources aid group insulin initiation education. |
| However, concerns following insulin education suggest that improvement is required and some nurses require training to address anxiety around insulin therapy. |
| Further work is needed to make insulin initiation groups equitable to all. |